DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Neochem Bio Solutions Limited — Updates

NSE 1 hr ago·10 Sept 2026, 7:11 am

Neochem BIO Solutions

Neochem Bio Solutions Limited has informed stock exchanges that its Managing Director, Swapnil R. Makati, has purchased 7,200 shares of the company. This disclosure was made under SEBI's Prohibition of Insider Trading regulations, which require insiders to report any significant changes in their shareholding to the market.

This move is generally viewed positively by the market as it signals the management's confidence in the company's future growth and valuation. For retail investors, it is a standard corporate governance practice that ensures transparency regarding insider trading activities.

Investors should monitor the shareholding pattern filed by the company in its subsequent regulatory filings to see if this purchase is part of a larger trend or a one-off transaction.